SLC29A3 Program

The SLC29A3 Program is a collaborative initiative committed to advancing research on conditions associated with the SLC29A3 gene. Affiliated with the Stanford School of Medicine’s Department of Pediatrics within the Division of Medical Genetics, our program is focused on improving the lives of patients and families affected by these rare hereditary autoinflammatory conditions.

In rare disease, progress takes more than rigorous science; it also requires a community united by purpose. With a commitment to advancing research and discovery for SLC29A3-related conditions, we are uniting expertise in genetics, lysosomal biology, immunology, translational science, and clinical care. Our goal is to accelerate understanding, foster open collaboration, and build the tools needed to shape future therapies. Based at Stanford University, our team has created a dedicated research hub with the goal of improving care and outcomes for children and families living with SLC29A3-related conditions.